Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ran Hou
Institution:
Fourth Hospital of Hebei Medical University
Observed institution:
Fourth Hospital of Hebei Medical University
ORCID:
0009-0001-4011-1309
Observed ORCID:
0009-0001-4011-1309
OpenAlex ID:
A5111232592
Prognostic gene HLA‐DMA associated with cell cycle and immune infiltrates in LUAD
2023
·
Ya‐jie Huang
, Jian‐kun He
, et al.
·
The Clinical Respiratory Journal
·
7
The necroptosis-related lncRNA ENSG00000253385.1 promotes the progression of esophageal squamous cell carcinoma by targeting the miR-16-2-3p/VDAC1 axis
2025
·
Xiaoyang Duan
, Jian Shi
, et al.
·
Scientific Reports
·
3
PDF
Exploring the immune landscape and drug prediction of an M2 tumor‐associated macrophage‐related gene signature in EGFR ‐negative lung adenocarcinoma
2024
·
Yajie Huang
, Yaozhong Zhang
, et al.
·
Thoracic Cancer
·
3
Comprehensive expression, prognostic and validation analysis of necroptosis-related lncRNAs in esophageal cancer
2024
·
Xiaoyang Duan
, Ran Hou
, et al.
·
Translational Oncology
·
3
Studies on the efficacy of pyrotinib in the treatment of HER-2 positive advanced solid tumors.
2020
·
Shaoshuang Fan
, Da Jiang
, et al.
·
Journal of Clinical Oncology
·
2
Multi‐omics analysis identifies a major histocompatibility complex class II‐associated antigen‐presenting cancer‐associated fibroblast‐like state linked to the nuclear factor erythroid 2‐related factor 2‐karyopherin subunit beta 1 axis in nonsmall cell lung cancer
2026
·
Fei Zheng
, Ruoying Deng
, et al.
·
Journal of Cell Communication and Signaling
·
1
Corrigendum to “Comprehensive expression, prognostic and validation analysis of necroptosis-related lncRNAs in esophageal cancer” [Transl Oncol. 2024 Aug;46:101983.]
2024
·
Xiaoyang Duan
, Ran Hou
, et al.
·
Translational Oncology
The clinicopathological characteristics, gene mutation characteristics and survival analysis of carcinoma of unknown primary origin.
2021
·
Yanzhi Cui
, Da Jiang
, et al.
·
Journal of Clinical Oncology
Efficacy and safety of fruquintinib in the treatment of poor patients with metastatic gastrointestinal cancer.
2020
·
Yanzhi Cui
, Da Jiang
, et al.
·
Journal of Clinical Oncology
Show more works
View as search
Works count:
9
Citation count:
19
H-index:
3
I10-index:
Year
Topic
Type